Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RIOT vs MRNA✓SelectedUSD · MRNARIOT vs MRNA performance historyLatest closeAs of-8.46%11/20
Stock and ETF performance explorer

RIOT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+838.2%
MRNA return
+786.4%
Excess return
+51.8%
Maximum drawdown
-95.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.5%-2.2%-6.3%-8.1%
7D-7.4%-12.7%+5.3%-5.5%
30D+15.8%-20.7%+36.4%+19.9%
3M-22.6%+46.3%-68.9%-27.5%
6M-31.4%+305.2%-336.7%-55.3%
YTD+28.1%+561.2%-533.1%-26.9%
1Y+27.0%+772.1%-745.1%-32.6%
3Y+43.4%+147.0%-103.6%-2.3%
5Y-55.1%-26.1%-29.1%-61.7%
All+838.2%+786.4%+51.8%+542.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling